Article Data

  • Views 1402
  • Dowloads 121

Original Research

Open Access

Misconceptions about routine colposcopy

  • P. Bösze1,*,

1Department of Gynaecology, Saint Stephen Hospital, Budapest, Hungary

DOI: 10.12892/ejgo201202129 Vol.33,Issue 2,March 2012 pp.129-133

Published: 10 March 2012

*Corresponding Author(s): P. Bösze E-mail: bosze@axelero.hu

Abstract

Colposcopy is practised in two ways: 1) to assess women with abnormal screening findings and/or clinically suspicious cervix (called referral celposcopy), and 2) as part of a routine gynaecological examination (referred to as routine colposcopy). There are several misconceptions about routine colposcopy probably reflecting the lack of experience in using routine colposcopy. Misconceptions include: routine colposcopy is screening colposcopy, it is time-consuming, expensive, a waste of time, and the training and maintaining of colposcopic expertise is probably not sufficient in this setting. Routine colposcopy, however, is not a screening tool, it is not screening colposcopy, but capable of identifying cervical precursors and cancer, and thereby reducing the false rates of cervical cancer screening (mainly cytology). Unlike referral colposcopy, routine colposcopy is an inexpensive and rapid procedure conducted as a part of a pelvic examination and has no, or minimal, discomfort that certainly does not exceed that of smear taking, neither is it associated with any psychological burden. Routine colposcopy allows gynaecologists to be convincingly sure in their findings; ensure women having normal epithelium; evaluate abnormalities in details (without biopsy) and counsel patients immediately to alleviate the psychological effects and prepare them for a possible abnormal smear; as well as help make a diagnosis of obscure lesions.

Keywords

Colposcopy; Abnormal cytology; Screening; Cervical cancer; CIN; AIS; Gynaecologic examination; Biopsy

Cite and Share

P. Bösze. Misconceptions about routine colposcopy. European Journal of Gynaecological Oncology. 2012. 33(2);129-133.

References

[1] Bösze P.: “Terminologia colposcopica: a personal perspective”. Eur. J. Gynaecol. Oncol., 2010, 32, 5.

[2] Jordan J., Arbyn M., Martin-Hirsch P., Schenck U., Baldauf J.-J., Da Silva D. et al.: “European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1”. Cytopathology, 2008, 19, 342.

[3] Navratil E., Burghardt E., Bajardi F., Nash W.: “Simultaneous colposcopy and cytology used in screening for carcinoma of the cervix”. Am. J. Obstet. Gynecol., 1958, 75, 1292.

[4] Lang W.R.: “Colposcopy: neglected method of cervical evaluation”. JAMA, 1958, 106, 893.

[5] Kyrgiou M., Tsoumpou I., Vrekoussis T., Martin-Hirsch P., Arbyn M., Prendiville W. et al.: “The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: The cochrane colposcopy & cervical pathology collaborative group (C5 group) approach”. Cancer Treat. Rev., 2006, 32, 516.

[6] Anderson M., Jordan J., Morse A., Sharp F.: “Integrated colposcopy”. Chapman & Hall Medical London, 1992, 264.

[7] Sidding T.S., Twigg J.P., Hammond R.H.: “Assessing the accuracy of colposcopy at predicting the outcome of abnormal cytology in pregnancy”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2006, 124, 93.

[8] Mitchell M.F., Schottenfeld D., Zortolero-Luna G., Cantor S.B., Richards-Kortum R.: “Colposcopy for diagnosis of squamous intraepithelial lesions: a meta-analysis”. Obstet. Gynecol., 1988, 91, 626.

[9] Pete I., Toth V., Bösze P.: “The value of colposcopy in screening cervical carcinoma”. Eur. J. Gynaecol Oncol., 1998, 19, 120.

[10] Bösze P.: “Colposcopy used in a primary setting (routine colposcopy): advantages and concerns”. Eur. J. Gynecol. Oncol., 2006, 27, 5.

[11] Chase D.M., Kalouyan M., DiSaia Ph.J.: “Colposcopy to evaluate abnormal cervical cytology in 2008”. Am. J. Obstet. Gynecol., 2009, www.AJOG.org

[12] Freeman-Wang T., Walker P.: “Psychosocial aspects of colposcopy”. In: Bösze P., Luesley D. “EAGC Course Book on Colposcopy”. Budapest, Primed-X Press, 2003, 165.

[13] European Federation of Colposcopy (EFC) Core competencies www.EFC.cx

[14] Kim J.J., Wright T.C., Goldie S.J.: “Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance”. JAMA, 2002, 287, 2382.

[15] Pretorius R.G., Peterson P., Azizi F., Burchette R.J.: “Subsequent risk and presentation of cervical intraepithelial neoplsia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less”. Am. J. Obstet. Gynecol., 2006, 195, 1260.

[16] Spielberg C., Goruch R., Lushene R.: “Manual for the strait-trait anxiety inventory”. Palo Alto, CA, 1970.

[17] Marteau T., Walker P., Giles J., Smail M.: “Anxieties in women undergoing colposcopy”. Br. J. Med J., 1990, 97, 859. Address

Submission Turnaround Time

Top